Viren K. Grover

MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.

Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA.

MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom.

PharmaIN Corp. develops affinity-based drug delivery solutions for biotech and pharmaceutical applications. It develops drug therapies using its proprietary, novel drug delivery platform called Protected Graft Co-polymer. The company was founded by Elijah M. Bolotin in 2000 and is headquartered in Bothell, WA.

Aptalis Pharma US, Inc. markets pharmaceutical products and services for the treatment of gastrointestinal diseases and disorders. It offers pancrelipase capsules, ursodiol tablets, porfimer sodium for injections, shake mixes, calorie boosters, clearance devices and multivitamin supplements. The firm also provides products for active ulcerative, liver diseases, pancreatic diseases, cystic fibrosis, chronic obstructive pulmonary disease, HIV/AIDS and cancer. The company was founded in 1991 and is headquartered in Wilmington, DE.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Kidd & Co. LLC (Kidd) is a private equity firm founded in 1976 by William J. Kidd. The firm is headquartered in Old Greenwich, Connecticut.

Part of UBS Group AG, Kidder Peabody & Co., Inc. /Non Retail Unit/ is a security brokers & dealers. The company is based in Staten Island, NY.

University of Akron provides public research education. Its programs include under graduate studies, graduate studies, international studies, law, and continuing education. The company was founded in 1870 and is headquartered in Akron, OH.

Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL.

African Wildlife Foundation, Inc. operates an international conservation organization focused on the African continent. The organization programs and conservation strategies are based on science and designed to protect both the wild lands and wildlife of Africa. The organization was founded in 1961 and is headquartered in Washington, DC.

Illinois Ventures LLC (Illinois Ventures) is a venture capital firm founded in 2000. The firm is headquartered in Champaign, Illinois.

Part of Grifols SA, Grifols Biologicals, Inc. is a company that produces protein therapies and products for patients. The company is based in Los Angeles, CA.

Regulatory Compliance Associates, Inc. provides compliance services to the pharmaceutical, medical device and biotechnical industries. Its services include regulatory affairs, compliance assurance, strategic consulting, product development, merger and acquisitions, medical devices, training, interim management, and project management. The company was founded by Steven Schultz and Mitch Januszewski in 2000 and is headquartered in Pleasant Prairie, WI.

Abbott Korea Ltd. engages in the distribution of medical equipment, reagents, medicines, nutritional products, infant formula and baby foods. The company was founded on May 24, 1988 and is headquartered in Seoul, South Korea.

Westinghouse Corp. is an American company that specializes in providing safe and innovative nuclear and other clean power technologies and services. With over 135 years of innovation, Westinghouse is the preferred partner for advanced technologies covering the complete nuclear energy life cycle. The private company supplied the world's first commercial pressurized water reactor in 1957, and its technology is the basis for nearly one-half of the world's operating nuclear plants.

PT Abbott Indonesia operates as a multinational healthcare company. The firm's products are available in all areas of care, from nutrition products and laboratory diagnostics to medical devices and pharmaceutical therapies. The company is headquartered in Pondok Indah, Indonesia.

Part of Ethypharm SAS, Altan Pharma Ltd. is an Irish company that develops, manufactures, and markets injectable medications. The company is based in Dublin, Ireland. The company was founded in 1998 by Guillermo A. Herrera. Guillermo A. Herrera has been the CEO since 1998. Altan Pharma was acquired by Ethypharm SAS from Malin Corp. Plc on October 01, 2021.

Mylan Laboratories SAS operates as a pharmaceutical company. The company is headquartered in Suresnes, France.

ASP Health, Inc. operates as medical device company. The company was founded in 2015 and is headquartered in Evanston, IL.

Azurity Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on the needs of patients, especially children and the elderly, requiring customized, user-friendly drug formulations. The firm?s products include Epaned, Qbrelis, Xatmep and FIRVANQ oral solutions. The company was founded in 1998 and is headquartered in Woburn, MA.

Reglagene Holding, Inc. engages in the provision of biotechnology solutions. It develops epigenetic medicines that regulate cancer genes. The company was founded by Vijay Gokhale, Laurence Hurley, and Richard Austin in November 2016 and is headquartered in Tucson, AZ.

Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation.